throbber
:.DISPLAY
`\.:..
`NOVEMBER 1987
`VOLUME 84
`NUMBER 22 88
`
`;
`, ~
`
`L: 1.'11\1\lL
`
`NATURn
`
`~.r-.,,.,E.S
`
`'"" ...... .... J .....
`
`Proceedings
`
`OF THE
`
`National Acadellly
`of Sciences
`
`OF THE UNITED STATES OF AMERICA
`
`PFIZER EX. 1081
`Page 1
`
`

`

`Proceedings
`OF THE
`National Academy
`of Sciences
`OF THE UNITED STATES OF AMERICA
`
`Officers
`of the
`Academy
`
`Editorial Board
`of the
`Proceedings
`
`FRANK PRESS , President
`JAMES D. EBERT, Vice President
`PETER H . RAVEN , Home Secretary
`WILLIAM E. GORDON, Foreign Secretary
`ELKAN R. BLOUT, Treasurer
`
`ROBERT H. ABELES
`GORDON A. BA YM
`WILLIAM F. BRACE
`RONALD BRESLOW
`MICHAEL J. CHAMBERLIN
`
`MAXINE F. SINGER, Chairman
`MARY-DELL CHILTON
`EDWARD E. DAVID, JR.
`STUART A. KORNFELD
`DANIEL E. KOSHLAND, JR.
`PETER D. LAX
`DANIEL NATHANS
`
`HERBERT E. SCARF
`SOLOMON H. SNYDER
`HAROLD V ARM US
`THOMAS A. WALDMANN
`FRANK H. WESTHEIMER
`
`Managing Editor: FRANCES R. ZWANZIG
`Senior Associate Editor: GARY T. CocKs
`Associate Editor: CAY BUTLER
`Associate Editor: JOHN M. MALLOY
`Associate Editor: MARILYN J. MASON
`Associate Editor: JANET L. MORGAN
`Associate Editor: T. PEARSON
`Associate Editor: DOROTHY P. SMITH
`Associate Editor: COLENE WALDEN
`Assistant Managing Editor: JOANNE D'AMICO
`
`Senior Production Editor: LYNN A. WASSYNG
`Production Editors: BARBARA A. BACON, RUTH E. CROSSGROVE, ScoTT C. HERMAN,
`MARGARET M. MADELEINE, JANET L. OVERTON, KATHLEEN RtJBY,
`DoN C. TIPPMAN, DEBORAH I. WEINER
`Administrative Assistants: DELORES BANKS, CYNDY MATHEWS
`Manuscript Coordinators: EvELYN JARMON, JACQUELINE PERRY
`Circulation: JULIA LITTLE, VIRGINIA TREADWAY
`
`Editorial correspondence: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, 2101 Constitution Avenue, Washing(cid:173)
`ton, DC 20418.
`Business correspondence: Circulation Office of the PROCEEDINGS, National Academy of Sciences, 2101 Constitution Ave(cid:173)
`nue, Washington, DC 20418.
`Information for Contributors: See issue Number 1, January 1987.
`Copyright: The National Academy of Sciences has copyrighted this journal as a collective work and does not own copy(cid:173)
`rights for individual articles. Requests for permission to reproduce parts of individual articles or for reprints of individual
`articles should be addressed to the authors. Microforms of complete volumes are available to regular subscribers only and
`may be obtained from University Microfilms, Xerox Corporation, Ann Arbor, MI 48103.
`Subscriptions: All correspondence concerning subscriptions should be addressed to the Circulation Office of the PROCEED(cid:173)
`INGS. Subscriptions are entered on a calendar year basis only. For 1988, subscription rates are as follows-in the United
`States: student/postdoctoral, $70; personal, $200; institutional , $250; elsewhere: student/postdoctoral, $110; personal,
`$240; institutional, $290. Information regarding air mail postage rates is available from the Circulation Office. Subscribers
`are requested to notify the Circulation Office of the PROCEEDINGS 6 weeks in advance of any change of address; also the
`local postmaster. The Academy is not responsible for nonreceipt of issues because of an improper address unless a change
`of address is on file. The notice of address change should list both the old and new addresses. Claims for replacement
`copies will not be honored more than 60 days after the issue date for domestic subscribers and not more than 90 days after
`the issue date for foreign subscribers.
`Back Issues: Volumes 79-83, January 1982 and thereafter, are available from the Circulation Office ·of the PROCEEDINGS.
`The price of a single issue is $13.00.
`PRINTED IN THE USA
`Second class postage paid at Washington , DC, and at additional mailing offices.
`PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (ISSN-0027-8424) is pub(cid:173)
`lished semimonthly by THE NATIONAL ACADEMY OF SCIENCES, 2/01 Constitution Avenue, Washington, DC 20418.
`
`© 1987 by THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA.
`
`POSTMASTER: Send address changes to: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED
`STATES OF AMERICA, 2101 Constitution Ave., Washington, DC 20418.
`
`PFIZER EX. 1081
`Page 2
`
`

`

`Proc. Nat/. A cad. S ci. USA
`Vol. 84, pp . 8075-8079, November 1987
`Immunology
`
`Three-dimensional structure of an antibody-antigen complex
`(immunoglobulins/ epitope /x-ray crystallography/ complementarity /lysozyme)
`STEVEN SHERIFF* , ENID w. SILVERTON*, EDUARDO A. PADLAN*, GERSON H. COHEN*,
`SANDRA J. SMITH-GILLt, BARRY c. FINZEL+§, AND DAVID R. DAVIES*
`'Laboratory of Molecular Biology, National Institute of Diabetes, Digestive and Kidney Diseases, Bethesda, MD 20892; t Laboratory of Genetics , National
`Cancer Institute , Bethesda, MD 20892 ; and lGenex Corporation. Gaithersburg, MD 20877
`
`Contributed by David R . Davies , July 30, /987
`
`ABSTRACT We have determined the three-dimensional
`structure of two crystal forms of an antilysozyme Fab-lysozyme
`complex by x-ray crystallography. The epitope on lysozyme
`consists of three sequentially separated subsites, including one
`long, nearly continuous, site from Gln-41 through Tyr-53 and
`one from Gly-67 through Pro-70. Antibody residues interacting
`with lysozyme occur in each of the six complementarity(cid:173)
`determining regions and also include one framework residue.
`Arg-45 and Arg-68 form a ridge on the surface of lysozyme,
`which binds in a groove on the antibody surface. Otherwise the
`surface of interaction between the two proteins is relatively flat,
`llthough it curls at the edges. The surface of interaction is
`approximately 26 x 19 A. No water molecules are found in the
`interface. The positive charge on the two arginines is comple(cid:173)
`mented by the negative charge of Glu-35 and Glu-50 from the
`heavy chain of the antibody. The backbone structure of the
`antigen, lysozyme, is mostly unperturbed, although there are
`some changes in the epitope region, most notably Pro-70. One
`side chain not in the epitope, Trp-63, undergoes a rotation
`oC"=180° about the CfJ-CY bond. The Fab elbow bends in the
`two crystal forms differ by 7°.
`
`Until recently knowledge of the structural aspects of anti(cid:173)
`body-antigen interactions has been based on the x-ray
`analysis of four Fab structures and on some complexes with
`hapten (1-5). Haptens were observed to bind in grooves or
`pockets in the combining sites of the New and McPC603
`Fabs, and these occupied a small fraction of the total
`available area of these sites . When haptens bind to these
`Fabs, no large conformational change occurs. However, one
`cannot rule out the possibility that the behavior of antibodies
`would be different when they are bound to larger antigens,
`such as proteins . For example, the interaction with a much
`greater fraction of the combining site might in itself be
`sufficient to induce conformational changes in the antibody.
`Also, the interacting surfaces might not possess the grooves
`and pockets observed for haptens, but might resemble more
`closely the kind of surface observed in other protein-protein
`interfaces, where exclusion of bound water is believed to play
`a key role. For this reason we undertook several years ago to
`investigate the crystal structures of complexes of the Fabs of
`several monoclonal antibodies to hen egg white lysozyme
`complexed with the lysozyme (6). In this paper we report the
`analysis of two different crystal forms of one of these
`complexes.
`The site on the lysozyme to which the antibody binds has
`been the subject of an extensive serological analysis (7)
`through a study of cross-reactivity with different avian
`lysozymes. The results of that analysis are in striking agree(cid:173)
`ment with the crystal structure observations and will be
`discussed.
`
`The publication costs of this article were defrayed in part by page charge
`payment. This article must therefore be hereby marked "advertisement"
`in accordance with 18 U.S. C. §1734 solely to indicate thi s fact.
`
`8075
`
`During the course of this analysis two reports of related
`x-ray studies of Fab--antigen complexes have appeared (8, 9) ,
`one being a description of another lysozyme-antilysozyme
`complex , although to a different epitope of the lysozyme, and
`the other describing a complex with the neuraminidase of
`influenza virus. The observations and conclusions from these
`two investigations differ in important ways from one another,
`and we describe below how our results can be related to
`them.
`
`MATERIALS AND METHODS
`Monoclonal antibody (mAb) HyHEL-5 and the Fab--lyso(cid:173)
`zyme complex were prepared as described previously (6, 7).
`Crystals were grown by vapor diffusion against 20% (wtj vol)
`polyethylene glycol 3400 (Aldrich) in 0.1 M imidazole hydro(cid:173)
`chloride, pH 7.0, 10 mM spermine with an initial protein
`concentration of7 mg/ ml. The crystals grow polymorphically
`in space group P21, differing principally in the length of the
`b axis , which was observed to vary between crystals in an
`unpredictable manner between 65 A and 75 A.
`One set of data on a crystal with cell dimensions of a = 54.9
`A, b = 65.2 A, c = 78.6 A, and f3 = 102.4° was collected at
`Genex (Gaithersburg, MD) using a single detector-single axis
`Nicolet-Xentronics (Madison, WI) area detector; 20,074
`observations yielded 7565 unique reflections. Lorentz, po(cid:173)
`larization , and absorption corrections were applied (10) , and
`the different frames were scaled together giving an overall
`merging Rsym of 0.044, where Rsym = Ihk/I;I7 - 1;!/Ihk/7,,.
`Greater than 90% of the theoretical data were observed to 4.5 A
`spacings, greater than 60% from 4.5 A to 4.0 A spacings , and
`about 40% from 4.0 A to 3.0 A spacings.
`A second data set was collected on a crystal with cell
`dimensions of a = 54.8 A, b = 74.8 A, c = 79.0 A, and f3 =
`101.8° at the University of California, San Diego, using the
`Mark II multiwire detector system with two detectors (11) ;
`38 ,689 reflections were collected from one crystal , of which
`15 ,673 were unique. Lorentz, polarization, and absorption
`corrections were applied, and the different frames were
`scaled together giving an overall merging R sym of 0.044. Of
`the 15,673 unique reflections, 15,166 are within 2.66-A
`resolution (86.3% of the theoretically observable) ; there are
`an additional 507 reflections between 2.66 and 2.54 A reso(cid:173)
`lution (18.7% of the theoretically observable).
`The structure was determined by molecular replacement
`using the program package assembled by Fitzgerald (12).
`Three probes were used : (i) tetragonal lysozyme (2L YZ)
`deposited by R. Diamond in the Protein Data Bank (13); (ii)
`CL + CHI of the McPC603 Fab (4); and (iii) V L + V H of the
`
`Abbreviations : CDR, complementarity-determining region; CDRs 1,
`2, and 3 for the light chain are referred to as Ll , L2, a nd L3 , and for
`the heavy chain a s H1, H2, and H3; mAb , monoclonal antibody ; C,
`constant region ; V , variable region .
`§Present address: Central Research and Development , E . I. Dupont
`Experimental Station ES 228/ 3168 , Wilmington , DE 19898.
`
`PFIZER EX. 1081
`Page 3
`
`

`

`8076
`
`Immunology: Sheriff e t a/.
`
`Proc. Nat/. A cad. Sci. USA 84 ( 1987)
`
`McPC603 Fab with the following residues removed from the
`model: VL-27C-31 and 91-95 ; and VH-30-31, 52B-54,
`61-64, 96-1001 , and 101. Residue numbering in Fabs through(cid:173)
`out this paper follows Kabat e t a/. (14); C and V represent
`constant and variable region s, respectively, and L and H
`refer to light and heavy chain, respectively . We oriented
`McPC603 Fab so that the axis of the elbow was parallel to the
`z axi s, which allowed us to observe most of the difference in
`elbow bend directly in the y rotation function ang,le (15) . The
`fast-rotation function (16) was used with 10- to 4-A resolution
`data and a radiu s of integration of 24 A. The rotation function
`of Lattman and Love (17) was used to refine the position of
`the peak for each probe. The Crowther-Biow (18) translation
`function was then used with 10- to 4-A resolution data and a
`step size of 0.02 unit cell lengths in a and c to determine the
`x ,z translations. We also used the program BRUTE, written
`by M. Fujinaga and R. Read , University of Alberta, with 5-
`to 4-A resolution data and 1-A step size to determine x ,z
`translations. Where the two methods agreed , we used
`BRUTE to hold one or two probes stationary and search for
`the translation of the second or third probe to solve the
`problem of relative origins in space group P2 1. The resulting
`model from this analysis was examined with the program
`FRO DO (19) on an Evans and Sutherland (Salt Lake City,
`Utah) PS300 picture system to ensure that the three probes
`were assembled in a plausible manner and that the crystal
`contacts were reasonable.
`The positions of the Fab and lysozyme were refined using
`the stereochemically restrained least-squares refinement
`package PRECOR/ CORELS (20). We first refined with three
`"domains ," lysozyme, VL + VH , and CL + CH1 , starting
`with 10- to 8-A resolution data and then extending the
`refinement to 7-A spacings and finally to 6-A spacings. The
`crystallographic R = ~hklllFol - IFcll/~llk/I Fol for the long
`b-axis form was 0.44 and for the short b-axis form was 0.49.
`We then divided the complex into five domains: lysozyme,
`VL, VH , CL, and CHl. At this point we replaced the VL
`domain of McPC603 with that of antibody 1539 (5), because
`it shares 75% sequence identity with the V L domain of mAb
`HyHEL-5 (21) . We also replaced the CH1 domain of
`McPC603, which is a murine IgA, with the CH1 domain of
`antibody KOL (3 , 13), which is a human IgG1 and shares 60%
`sequence identity with the murine IgG1 CH1 domain of mAb
`HyHEL-5 . At this stage of refinement for both crystal forms
`the R was 0.42 for 10- to 6-A resolution data.
`At this point we concentrated on the long b-axis form
`because the data set extended to higher resolution. We
`removed from the model the side chains of amino acids that
`were not identical to the mAb HyHEL-5 sequence (ref. 21
`and A. B. Hartmann, C. P. Mallett, and S.J.S.-G. , unpub(cid:173)
`lished work) and also omitted entire residues of the following
`complementarity-determining regions (CDRs) : L3 (residues
`91-95) , H2 (residues 52B-54) , and H3 (residues 97-100); (see
`abbreviations footnote). We refined the model against data
`from 10- to 2.5-A resolution using the stereochemically
`restrained least-squares refinement package PROTIN / PROL(cid:173)
`SQ (22) . We first refined only the positional parameters using
`an overall isotropic B until the R = 0.344. We then used
`FRODO to rebuild the model. In the electron-density map at
`this stage there was excellent density for the deleted L3 and
`moderately good density for the deleted H2 and H3. Also, in
`most cases , electron density was apparent for side chains that
`had been omitted from the model. Following this , we refined
`the model adding individual isotropic B factors until the R =
`0.270, and then we examined the model with molecular
`graphics and rebuilt parts of the model , especially H3. We
`once again refined until the R = 0.249. At this stage we
`included an overall ani sotropic D.B (23) , which had values of
`Mu = - 5.89, M 13 = 2.15 , M 22 = 8.44, and M 33 = -2.55
`and which correlates with the variable b-axis length , suggest-
`
`ing the lattice contacts along the b axis are weak. We then
`omitted all of the interacting residues in lysozyme , refi ned the
`model, calculated an electron-density map, and examined it
`to determine whether our interpretation of the position of
`these residues was correct. We did the same thing with the
`interacting residues on the Fab . After making minor changes
`to the structure we refined again, yielding R = 0. 245 with an
`rms deviation from ideal bond lengths of 0.012 A. We have
`deposited the coordinates from this stage of the refinement in
`the Protein Data Bank (13).
`We have estimated the rms positional error to be 0.40 A by
`the method of Luzzati (24) . In describing the results, hydro(cid:173)
`gen bonds and salt links were limited to pairs of appropriate
`atoms with an interatomic distance of < 3.4 A. Maximum van
`der Waals contact distances were defined as in Sheriff eta/.
`(25). Contacting surface area was c~lculated with program
`MS (26) using a probe radius of 1.7 A and standard van der
`Waals radii (27) .
`
`RESULTS
`Fig. 1a shows the C" skeleton of the HyHEL-5 Fab(cid:173)
`lysozyme complex. V H and V L• and CH1 and CL adopt the
`canonical relationships observed in other Fabs. The main
`difference between the two crystal forms is the elbow bend
`of the HyHEL-5 Fab , which is 161° in the long b-axis form
`and 154° in the short b-axis form.
`The contact between the antibody-combining site and the
`lysozyme epitope is extensive and involves many residues.
`The calculated buried surface (solvent inaccessible) area is
`about 750 A2 on the surface of both the Fab and lysozyme
`(= 14% of the surface). The interaction between the two
`proteins is very tight, and there are no water molecules
`between the combining site and the epitope. The current
`model contains three salt links and ten hydrogen bonds.
`Glu-50 (H2) forms salt links to both Arg-45 and Arg-68 of
`lysozyme , and Glu-35 (H1) forms a salt link to Arg-68. There
`are 74 van der Waals contacts .
`The epitope on lysozyme consists of three oligopeptide
`segments (Fig. 1b). The first consists of Gln-41, Thr-43 ,
`Asn-44, Arg-45, Asn-46, Thr-47, Asp-48 , Gly-49, and Tyr-53,
`which are in contact, and Thr-51 and Asp-52 , which are partly
`buried by the interaction . This segment is essentially one long
`continuous subsite, which consists of two {3-strands connect(cid:173)
`ed by a bend involving residues 46 through 49 (28). The
`second segment consists of the contacting residues Gly-67,
`Arg-68 , Thr-69, and Pro-70; and the partly buried residues
`Asn-65 , Asp-66, Gly-71 , and Ser-72. This second segment has
`the form of a rambling loop and contains part of an ex.te.n(cid:173)
`sively studied , disulfide-linked antigenic peptide that ehc1ts
`antibodies that could cross-react with native lysozyme (29).
`Arg-68 in this subsite has been identified as a "critical"
`residue to the epitope (7) . The third segment consists of the
`directly interacting Leu-84 and the partly buried residues
`Pro-79, Ser-81 , and Ser-85. Arg-61 , which is in none of.the
`segments , is also partly buried upon complex formatwn.
`The surface of the epitope is extensive (23 A between the
`most distant C" atoms) and relatively flat except for a
`protruding ridge made up of the side chains of Arg-45 and
`Arg-68, and curling back at the edges (Fig. 1d).
`.
`The antibody-combining site involves residues from all SIX
`CDRs (30). Each of these CDRs contributes at least one
`residue to the interaction with lysozyme , and most contribut~
`several residues (Fig. 1c). Trp-47, which is considered part 0
`the heavy chain framework, also interacts with lysozym~·
`The other interacting residues are Asn-31 , Tyr-32, Asp-4 d
`Trp-91 , Gly-92 , Arg-93 , and Pro-95 from the light cham; a;
`8
`Trp-33 , Glu-35 , Glu-50, Ser-54, Ser-56, Thr-57, As.n-
`'
`Gly-95 , and Tyr-97 from the heavy chain . Additional res1due~
`that are at least partly buried by the interaction but do n(?
`directly contact are Ser-29, Val-30, Tyr-34, and Arg-46 10
`
`PFIZER EX. 1081
`Page 4
`
`

`

`Immunology: Sheriff et a/.
`
`Proc. Nat/. A cad. Sci. USA 84 ( 1987)
`
`8077
`
`(a) Stereo diagram of ca trace
`FIG. 1.
`of lysozyme-HyHEL-5 complex . Lyso(cid:173)
`zyme (blue), lysozyme epitope (red), light
`chain (yellow), heavy chain (green), and
`CDRs (magenta) . (b) Stereo diagram of
`lysozyme highlighting epitope. Residues
`not in contact with mAb HyHEL-5 have
`only backbone atoms shown (blue) . Resi(cid:173)
`dues in epitope (red) and residues in the
`first subsite not directly in contact with the
`Fab (yellow). The first subsite (residues 41
`through 53) is toward the bottom of the
`figure , starting at Gln-41 at the lower left
`and going across to Thr-47 at lower right
`and then looping back from Asp-48 to
`Tyr-53; the second subsite (residues 67
`through 70) is at the upper right ; and the
`third subsite (lle-84) is toward the upper
`left. The side chains of Arg-45 and Arg-68
`are more or less vertical and just to the
`right of center. (c) Stereo diagram of mAb
`HyHEL-5 Fab highlighting CDRs and con(cid:173)
`tacting residues . Framework residue s
`(blue) and CDR, but not in contact (yel(cid:173)
`low) , have only backbone atoms shown.
`Contacting residues (red) are shown in
`toto . The light chain is on the left , and the
`heavy chain on the right. L1 , lower left ;
`L2, upper left ; L3 , center bottom; H1 ,
`upper right; H2, lower right ; and H3 , cen(cid:173)
`ter top. Trp-47 from the heavy chain frame(cid:173)
`work is just to the right of L3, and Glu-35
`(H1) and Glu-50 (H2) are directly above
`Trp-47 . (d) Stereo diagram of mAb Hy(cid:173)
`HEL-5 with complementary surface of ly(cid:173)
`sozyme epitope superimposed. Residues
`not in contact with lysozyme (blue). Resi(cid:173)
`dues in contact with lysozyme (red). Ly(cid:173)
`sozyme buried surface (yellow dots) . Ori(cid:173)
`entation is identical to Fig. 1c. Bright areas
`around edges illustrate curling of surface.
`(e) Stereo diagram of superposition of
`backbone atoms of lysozyme in tetragonal
`crystal form on lysozyme in complex with
`mAb HyHEL-5 . Tetragonal lysozyme
`(blue). Lysozyme in complex with mAb
`HyHEL-5 (red). White results from exact
`superposition of red and blue. Epitope is at
`the right. Pro-70 at upper right can be seen
`to differ in the two structures. Loop at
`Thr-47 and Asp-48 also shows differences
`in backbone at lower right.
`
`1ra1ne,.vm·k region 2) from the light chain and Ser-30, Asp-31,
`-32, Leu-52, Gly-55, Asn-96, and Asp-98 from the heavy
`chain. Only 30% of the residues in the CDRs are actually in
`COntact with lysozyme . If one adds the residues that are at
`least partly buried , this fraction rises to 48%. The surface of
`interaction is quite broad and extensive with the ca atoms of
`interacting combining site residues separated by as much as
`28 A. There is a groove on the surface ofthe antibody running
`from L3 to H3 and between Trp-91 of L3 and Trp-33 of Hl
`(Fig. 1d). Arg-45 and Arg-68 of lysozyme fit into this groove,
`Placing them in position to form salt links to Glu-50 (H2) and
`Glu-35 (Hl).
`We examined the lysozyme and Fab structures for indica(cid:173)
`tion at this degree of refinement of any significant confor(cid:173)
`mational change that may have occurred as a result of their
`
`assoc.at1on. The structure of hen egg lysozyme has been
`determined in four crystal forms, thus providing a database
`for comparing the structure of lysozyme in different envi(cid:173)
`ronments. The tetragonal lysozyme coordinates used in this
`comparison (D. C. Phillips, personal communication) dif(cid:173)
`fered slightly from those used for structure determination
`(rms difference = 0.32 A for 516 main-chain atoms). We
`superimposed the tetragonal lysozyme coordinates onto the
`lysozyme in our complex, using all main-chain atoms, both
`including and excluding atoms from residues that are in(cid:173)
`volved in interactions with the antibody-combining site on
`the Fab. Qualitatively we see the same behavior with both
`procedures, and we report numbers calculated when residues
`were excluded (Fig. le). For these lysozymes , the backbone
`structures are nearly identical (rms difference = 0.48 A for
`
`PFIZER EX. 1081
`Page 5
`
`

`

`8078
`
`Immunology: Sheriff et a/.
`
`Proc. Nat/. A cad. S ci. USA 84 ( 1987)
`
`516 atoms) . However, we do see some c~anges in the region
`of the epitope (rms difference = 0.64 A for 96 atoms). In
`particular, the C" ofPro-70 has moved about 1. 7 A, which can
`be accounted for by a hydrogen bond of the carbonyl oxygen
`and the hydroxyl of Tyr-97 (H3).
`There are also some changes in the side-chain atoms (rms
`difference = 1.22 A for 429 atoms). The side chains of
`residues not involved in the epitope (excluding Trp-63) show
`an rms difference of 1.12 A for 420 atoms. Comparing side
`chains of residues involved in the epitope gives an rms
`difference of 1.20 A for 55 atoms. The largest side-chain
`difference is Trp-63, which is not in the epitope and which
`appears to have flipped 180° around the Cf3-c-r bond.
`Although the current electron-density maps strongly favor
`movement, there is some ambiguity because there is a tail of
`electron density that points , more or less, in the direction of
`the original side-chain conformation. Preliminary refinement
`of the short b-axis form strongly suggests the movement of
`the Trp-63 side chain. Many of the other large differences are
`in residues that are part of the epitope. In particular, the side
`chains of Arg-45 and Arg-68 in the tetragonal crystal form, the
`triclinic crystal form, and the complex with the antibody are
`within hydrogen-bonding distance of one another, but in none
`of the three are the side chains in the same position relative
`to the backbone.
`To ascertain whether any changes have taken place in the
`Fab in the complex, we need crystals of the uncomplexed
`Fab , but so far we have been unable to grow such crystals
`large enough for diffraction studies. However, the fact that
`the molecular replacement technique worked so well shows
`that the positions of CL relative to CHI and of V L relative to
`V H are basically unchanged from the "canonical" structures
`found in Fab fragments from myeloma proteins. This result
`differs from the result of Colman eta/. (9), who report that V L
`and V H form a non-canonical pairing in their antineuramin(cid:173)
`idase-neuraminidase complex.
`
`DISCUSSION
`
`Our results confirm the identification of the epitope on
`lysozyme for HyHEL-5 based on serological studies (7). In
`those studies , epitope mapping was accomplished by ana(cid:173)
`lyzing the cross-reactivity of homologous proteins in the
`antibody-antigen reaction. The limited sequence variation
`among these cross-reacting proteins was utilized to pinpoint
`the residues that were important in the particular binding
`interaction . The present crystallographic results provide
`strong evidence for the validity of epitope mapping by
`serological techniques .
`The HyHEL-5-Iysozyme complex described here and the
`two other antibody-antigen complexes whose structures have
`been reported share some common features. For example, in
`all three cases , the interaction involves all of the CDRs of the
`antibody. The surface area of the combining site of the
`antibody that is buried upon complexing with antibody is 750
`A2 for HyHEL-5 , 690 A2 for the antilysozyme Dl.3 Fab (8),
`and not specified for the antineuraminidase NC41 Fab (9),
`where the third CDRs of both light and heavy chains have not
`yet been completely modeled.
`Although the areas of interaction are comparable for the
`HyHEL-5 and Dl.3 antibody, the association constant is
`greater for HyHEL-5 than for Dl.3 antibody [2.5 x 109
`(M. E. Denton and H . A. Scheraga, personal communica(cid:173)
`tion) vs. 4.5 x 107 (8)] . This indicates that the area of
`interaction alone cannot be the total determinant of the
`attraction between the antibody and antigen ; undoubtedly ,
`other factors such as electrostatic and hydrogen bonding play
`a role. In this connection, the favorable electrostatic inter(cid:173)
`actions involving Arg-45 and Arg-68 of lysozyme and Glu-35
`(Hl) and Glu-50 (H2) of the Fab, and the shape complemen-
`
`tarity between the Arg-45 , Arg-68 side-chain ridge on lyso(cid:173)
`zyme and the groove on the Fab are relevant. In contrast
`there are no electrostatic interactions between Dl. 3 antibody
`and lysozyme (8). We note that when Arg-68 becomes a
`lysine, as it does in bobwhite quail , the HyHEL-5 antibody
`binds with less avidity by a factor of 103 (7) , so that shape and
`hydrogen-bonding capacity of the charged group are also
`crucial. In antibody Dl.3 , H3 plays a dominant role in the
`antibody-antigen interaction (8). However, in HyHEL-5 , H2
`and L3 play the dominant role contributing six and four
`residues , respectively, and approximately equal surface ar(cid:173)
`eas to the interaction. CDR 1 of the light chain (Ll), Hl, and
`H3 play a lesser role by each contributing two residues and
`only 50-60% of the surface area of H2 and L3.
`The lysozyme epitope for HyHEL-5 consists principally of
`two continuous segments of polypeptide chain, residues
`41-53 and 65-72. The lysozyme epitope for antibody Dl.3
`again involves two continuous segments of the protein,
`residues 18-27 and 116-129 (8). This similarity is remarkable,
`but it is probably coincidental because the epitope for NC41
`Fab on the neuraminidase involves four segments , 368-370,
`400-403, 430-434, and parts of 325-350 (9). It is interesting
`that the two continuous segments in the lysozyme epitope for
`mAb HyHEL-5 have been reported to have high mobility in
`several lysozyme structures (31).
`Conformational changes in the Fab that result from antigen
`binding cannot be quantitated because in none of the three
`cases so far reported has the structure of the uncomplexed
`Fab been analyzed. It should be noted that antibodies
`frequently have large insertions into the CDRs, and these
`sometimes project into the solvent and cannot be localized
`with certainty by x-ray diffraction. L1 in McPC603 Fab is an
`example of this (4). In any interaction involving McPC603
`Fab with a large antigen , it is likely that such a loop would
`move. However, Colman eta/. (9) have reported a difference
`in the relationship of V L to V H in NC41 Fab. We have
`duplicated the calculations in Table 1 of Colman et a/. (9) with
`results that are essentially in agreement with theirs and
`extended the table to include Fabs 1539 and HyHEL-5. We
`find that the relative disposition of the two variable domains
`in the NC41 Fab does lie at the extreme of the values
`observed. Whether this is the result of binding to antigen or
`the result of the interaction of hypervariable residues in the
`interface cannot be determined at present. We should point
`out, however, that the NC41 Fab--neuraminidase complex
`has been elucidated to only 3.0-A resolution and has been
`subjected to only preliminary refinement (R = 0. 35). These
`conclusions need to be confirmed by further refinement.
`Amit eta/. (8) have observed that no large conformational
`changes have occurred in lysozyme upon binding to the D1.3
`Fab. Over most of the molecule we find essentially the same
`results , although some changes do occur in both the back(cid:173)
`bone and the side chains. In particular, the flipp ing of the
`Trp-63 side chain, if confirmed by further refinement, to(cid:173)
`gether with movement of Pro-70 are the most notable of these
`changes . Colman eta/. (9) have also reported a few significant
`differences between the structure of the neuraminidase alone
`and that in the complex with NC41 Fab, although here, to~,
`we must await confirmation from further refinement. It 15
`apparent that some deformation of the antigen can occu;,
`especially when the epitope is in a flexible part of t e
`structure, as in HyHEL-5-Iysozyme complex. Indeed, flex(cid:173)
`
`ibility has been implicated in the antigenicity of prote_ins (3;,
`
`33) and could aid in the binding of antibody to ant1gen Y
`allowing the latter to complement more closely the structure
`of the antibody-combining site.
`d
`It has been hypothesized that changes in the elbow ben f
`may signal antigen binding (34). The different crystal for~s ~e
`the HyHEL-5-lysozyme complex are the first example o t
`same antibody-antigen complex showing different elboW-
`
`PFIZER EX. 1081
`Page 6
`
`

`

`Immunology: Sheriff et a/.
`
`Proc. Nat/. A cad. Sci. USA 84 ( 1987)
`
`8079
`
`bend angles . The values observed here lie in the middle of the
`spectrum of observed elbow bends ranging from 133o to
`zl80° (35). There appears to be no correlation between
`observed values of elbow bends for different Fabs and
`binding to hapten or antigen. It is therefore likel y that this
`range of values is simply an indication of flexibility of this part
`of the antibody molecule .
`In conclusion , the results observed for the binding of
`antibodies to protein antigens have many features in common
`with the binding of haptens . For example, it is clear that
`charge neutralization in the interface plays an important role .
`The principal difference in the case of the larger antigens is
`the much greater area of the complementary surfaces that are
`brought into contact with consequent exclusion of water
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket